Tennis Elbow Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Elbow Stiffness Treatment Market Trends and the market is segmented by Treatment Type (Surgical Therapies (Arthroscopic Surgery and Open Surgery) and Non-surgical Therapies (Extracorporeal Shock Wave Therapy, Braces, Medications. and Physical Therapies) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Tennis Elbow Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Tennis Elbow Treatment Market Size

Tennis Elbow Treatment Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 4.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Tennis Elbow Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Tennis Elbow Treatment Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Tennis Elbow Treatment Market Analysis

The Tennis Elbow Treatment Market is expected to register a CAGR of 4.1% during the forecast period.

During the COVID-19 pandemic, the tennis elbow treatment market encountered a setback due to the imposed lockdown, deferral, and cancellation of a range of sports events that led to a decline in sports and related other injuries. In March 2020, Tokyo Olympics and Paralympics were postponed to 2021 by the International Olympic Committee. Similarly, an article published in February 2022 recorded around a 34.6% decrease in sports-related emergency department visits in 2020. In addition, as per the same source, the majority of the sports-related ED visits were of patients aged 22 years (55.7%). Such incidents negatively impacted market growth. The medical professionals and specialists were instructed to address only the emergency and critical surgical operations during this period.

All these factors have affected product sales with declined hospital visits during the initial phases of the pandemic. Additionally, the manufacturing of tennis elbow pharmaceuticals was also affected during the first wave of the pandemic, which negatively impacted market growth in 2020.

However, in 2021, the tennis elbow treatment industry showed a sturdy recovery, owing to an increasing relaxation in restrictions leading to a rise in the number of sports activities globally. As per the data published by the NSC Injury Facts, in July 2021, the prevalence of sports and recreational injuries increased by 20% in the year 2021. Thus, the increasing number of sport-related injuries among the population is expected to increase the market growth over the forecast period. This is expected to grow further in the upcoming years.

The rising burden of sports-related and tennis elbow injuries is the key factor driving the market growth. For instance, as per an article published in February 2022, about 8.6 million athletes suffer from sports-related injuries each year in the United States. As per the data published by the NSC Injury Facts, in July 2021, about 3.2 million people received treatment in the emergency department for injuries involving sports and recreational equipment such as exercise, cycling, and basketball. This is expected to increase the risk of tennis elbow injuries, which is anticipated to increase the demand for effective treatment, propelling market growth.

Additionally, an article published in BMC Sports, Science, Medicine and Rehabilitation in January 2022 found that the administration of hyaluronic acid in patients suffering from tennis elbow has reduced the pain within three months. Thus, the use of hyaluronic acid injection is considered the best option for treating tennis elbow pain as compared to surgery and other treatment options. This is anticipated to boost market growth over the forecast period.

The rising geriatric population is also expected to increase the market growth. For instance, as per an article published in NCBI in August 2022, elderly people are at high risk of elbow injuries and traumatic fractures. The symptoms of tennis elbow usually appear at the age of 40 to 60 years. Also, as per 2022 statistics published by UNPFA, about 64% of the population living in Germany was between the ages 15-64 years in 2022, and 22% of the population was aged 65 years and above in 2022. Thus, the high number of elderly people living in the country is expected to develop elbow-related injuries as the muscles are more susceptible to overuse in middle and older age. This is anticipated to fuel the demand for effective treatment options and hence boost the market growth.

However, the sluggish commercialization of new effective therapies is expected to hamper the market growth over the forecast period.

Tennis Elbow Treatment Industry Overview

The tennis elbow treatment market is consolidated in nature. Various companies are striving to gain market share by adopting competitive strategies, such as joint ventures and research partnerships. Some key players operating in the market include 3M, AKSIGEN, BTL, DJO Global Inc., Johari Digital, Ossur Corporate, OttoBock HealthCare, Teikoku Pharma USA Inc., Veritas Health LLC, and Zimmer Biomet. The players are constantly involved in strategic initiatives, such as new product launches, technological advancements, regional expansion, and mergers and acquisitions in order to gain deeper penetration.

Tennis Elbow Treatment Market Leaders

  1. DJO Global, Inc.

  2. Teikoku Pharma USA, Inc

  3. Zimmer Biomet

  4. 3M

  5. AKSIGEN

  6. *Disclaimer: Major Players sorted in no particular order
Tennis Elbow Treatment Market - cl.png
Need More Details on Market Players and Competiters?
Download PDF

Tennis Elbow Treatment Market News

  • In April 2022, Chen Yueh announced that it is conducting a Phase III clinical study to find out functional and electromyographical changes after platelet-rich plasma and dextrose injection in chronic lateral epicondylitis, in Taiwan.
  • In March 2022, the Istanbul university announced that it is conducting a clinical trial to compare the effectiveness of platelet-rich plasma, saline (0.9 NACI), and betametazon injection techniques in the treatment of elbow lateral epicondylitis. The trials are expected to end on January 2023.

Tennis Elbow Treatment Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Cases of Lateral Epicondylitis and Sport-related Injuries
    • 4.2.2 Increase in Target Population Base
    • 4.2.3 Technological Advancement and Favorable Reimbursement
  • 4.3 Market Restraints
    • 4.3.1 Sluggish Commercialization of New Effective Therapies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Treatment Type
    • 5.1.1 Surgical Therapies
    • 5.1.1.1 Arthroscopic Surgery
    • 5.1.1.2 Open Surgery
    • 5.1.2 Non-surgical Therapies
    • 5.1.2.1 Extracorporeal Shock Wave Therapy
    • 5.1.2.2 Braces
    • 5.1.2.3 Medications
    • 5.1.2.4 Physical Therapies
  • 5.2 Geography
    • 5.2.1 North America
    • 5.2.1.1 United States
    • 5.2.1.2 Canada
    • 5.2.1.3 Mexico
    • 5.2.2 Europe
    • 5.2.2.1 Germany
    • 5.2.2.2 United Kingdom
    • 5.2.2.3 France
    • 5.2.2.4 Italy
    • 5.2.2.5 Spain
    • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
    • 5.2.3.1 China
    • 5.2.3.2 Japan
    • 5.2.3.3 India
    • 5.2.3.4 Australia
    • 5.2.3.5 South Korea
    • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
    • 5.2.4.1 GCC
    • 5.2.4.2 South Africa
    • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
    • 5.2.5.1 Brazil
    • 5.2.5.2 Argentina
    • 5.2.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 AKSIGEN
    • 6.1.3 BTL
    • 6.1.4 DJO Global Inc.
    • 6.1.5 Johari Digital
    • 6.1.6 Ossur Corporate
    • 6.1.7 OttoBock HealthCare
    • 6.1.8 Teikoku Pharma USA Inc.
    • 6.1.9 Veritas Health LLC
    • 6.1.10 Zimmer Biomet
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Tennis Elbow Treatment Industry Segmentation

As per the scope of the report, tennis elbow (lateral epicondylitis) is a painful condition caused by the repetitive motion of the arms and elbow. A kind of tendinitis, the condition involves swelling of tendons and is identified on medical examination. Lateral epicondylitis (tennis elbow) is an inflammatory condition observed usually in tennis players, baseball players, swimmers, carpenters, plumbers, and anyone who repeats an arm motion over and over.  

The tennis elbow treatment market is segmented by treatment type (surgical therapies (arthroscopic surgery and open surgery) and non-surgical therapies (extracorporeal shock wave therapy, braces, medications, and physical therapies) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across significant regions globally. The report offers the value (in USD million) for the above segments.

By Treatment Type Surgical Therapies Arthroscopic Surgery
Open Surgery
Non-surgical Therapies Extracorporeal Shock Wave Therapy
Braces
Medications
Physical Therapies
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Tennis Elbow Treatment Market Research FAQs

What is the current Tennis Elbow Treatment Market size?

The Tennis Elbow Treatment Market is projected to register a CAGR of 4.1% during the forecast period (2025-2030)

Who are the key players in Tennis Elbow Treatment Market?

DJO Global, Inc., Teikoku Pharma USA, Inc, Zimmer Biomet, 3M and AKSIGEN are the major companies operating in the Tennis Elbow Treatment Market.

Which is the fastest growing region in Tennis Elbow Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Tennis Elbow Treatment Market?

In 2025, the North America accounts for the largest market share in Tennis Elbow Treatment Market.

What years does this Tennis Elbow Treatment Market cover?

The report covers the Tennis Elbow Treatment Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Tennis Elbow Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Lateral Epicondylitis Treatment Industry Report

Statistics for the 2025 Tennis Elbow Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Tennis Elbow Treatment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Lateral Epicondylitis Treatment Market Report Snapshots